Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma
A Randomized Controlled Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma
Sponsor: Canadian Institutes of Health Research (CIHR)
Listed as NCT00120263, this NA trial focuses on Acute Renal Failure and Multiple Myeloma and remains completed. Sponsored by Canadian Institutes of Health Research (CIHR), it has been updated 6 times since 1998, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Apr 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Apr 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Sep 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Institutes of Health Research (CIHR)
- London Health Sciences Centre
- The Kidney Foundation of Canada
For direct contact, visit the study record on ClinicalTrials.gov .